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P-wave Variability and Atrial 
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The analysis of P-wave template has been widely used to extract indices of Atrial Fibrillation (AF) risk 
stratification. The aim of this paper was to assess the potential of the analysis of the P-wave variability 
over time in patients suffering from atrial fibrillation. P-wave features extracted from P-wave template 
together with novel indices of P-wave variability have been estimated in a population of patients 
suffering from persistent AF and compared to those extracted from control subjects. We quantify the 
P-wave variability over time using three algorithms and we extracted three novel indices: one based on 
the cross-correlation coefficients among the P-waves (Cross-Correlation Index, CCI), one associated to 
variation in amplitude of the P-waves (Amplitude Dispersion Index, ADI), one sensible to the phase shift 
among P-waves (Warping Index, WI). The control group resulted to be characterized by shorter P-wave 
duration and by a less amount of fragmentation and variability, respect to AF patients. The parameter 
CCI shows the highest sensitivity (97.3%) and a good specificity (95%).
The importance of the analysis of the P-wave in the stratification of patient suffering from atrial fibrillation (AF) is 
worldwide accepted. Nowadays it is recognized that not only the P-wave duration, but also the P-wave morphol-
ogy has the potential to give information about the anatomical substrate predisposing to AF1,2.
Technically, given the low amplitude of this portion of the ECG signal respect to the background noise, 
the analysis of the P-wave features have been so far performed on a model of the P-wave, the P-wave template, 
obtained by the averaging technique.
However, sophisticated ECG systems and some modern electrocardiographs have suitable noise rejection and 
resolution for ECG acquisition to allow the analysis of the P-wave on a beat-by-beat basis. It is thus important 
nowadays to attempt studying these never analyzed aspects related to the beat-to-beat depolarization of the atria, 
to ameliorate the comprehension of arrhythmic phenomena.
To our knowledge, few papers have been published assessing the P-wave variability over time in patients suf-
fering from AF. Recently Martinez and co-authors focused on the time course of some P-wave features with the 
aim of extracting predictors of AF episode onset3,4.
The aim of this paper was to analyze the potential of P-wave variability for indicating atrial substrate modifica-
tion correlated with AF. To this aim, P-wave features extracted from P-wave template together with novel indices 
of P-wave variability have been estimated in a population of patients suffering from persistent AF, and compared 
to those extracted from control subjects.
Methods
ECG acquisition. Study population consisted of 73 patients suffering from persistent AF (43 males, age 
69.5 ± 9.3 years) and 20 control subjects (11 males, age 66.8 ± 6.7 years).
Patients suffering from persistent AF were selected among patients underwent electrical cardioversion for 
nonvalvular persistent AF at the Experimental, Diagnostic and Specialty Medicine Department of the University 
of Bologna over a 24-month period. Control group was composed by patients without atrial diseases, prior car-
diac diseases and history of AF, hospitalized for not cardiovascular factors. Table 1 shows the clinical character-
istics of the study population.
ECG has been recorded, after informed consent, in AF patients after the sinus rhythm was restored by elec-
trical cardioversion. ECG signals were acquired using a 16-lead mapping system for high-resolution biopoten-
tial measurement (ActiveTwo, Biosemi, The Netherlands), sample frequency 2 kHz, 24 bit resolution, 0–400 Hz 
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bandwidth. A ten minute ECG recording was collected in each subject. 10 out of 16 electrodes were positioned on 
the thorax to obtained the standard 12-lead ECG.
The diagnosis of sinus rhythm after electrical cardioversion was based on diagnosis made by an expert cardi-
ologist on the basis of 12-lead ECG, as in normal clinical practice.
The protocol foresaw also an ECG recording after 3 and 6 months since cardioversion. The analysis of these 
data, not reported in this paper, showed that ECG does not change over time in terms of P-wave features.
All clinical investigations were conducted according to Declaration of Helsinki principles. The study was 
approved by the joint research committee of the Department for Technologies and Health of the National Italian 
Institute of Health and the Cardiovascular Department of the University of Bologna.
P-wave extraction and analysis. After extracting the P-waves in a 200 ms-long window (400 samples) 
starting 300 ms before the corresponding R-wave, a beat-by-beat linear piecewise interpolation was used to 
remove baseline wander, on each P-wave. Fiducial points for linear interpolation were taken from TP and PQ 
tracks of each beat. Then, a matrix of the P-waves has been created containing all P-waves except ectopic atrial 
beats or P-waves with excessive noise or recording artifacts. Exclusion criterion was based on conventional tem-
plate matching of each P-wave, with a cross-correlation coefficient lower than 0.7 respect to the current template. 
We empirically found that this value threshold for the cross-correlation coefficient guarantees that only ectopic 
atrial beats or P-waves with excessive noise or recording artifacts were excluded. Classical time-domain and mor-
phological analysis has been performed on P-wave template5–7.
To estimate P-wave variability 3 algorithms have been implemented, based on cross-correlation function, 
butterfly plots and dynamic time warping.
P-wave time-domain and morphological analysis. Template extraction by averaging technique has 
been performed as described in5.
P-wave duration has been estimated for each patient and for each lead, using the algorithm described in5. 
For each patient, maximum and minimum P-wave duration in any of the 12 leads (Pmax, Pmin) as well as P wave 
dispersion (Pdisp = Pmax − Pmin) have been extracted.
P-wave morphology has been quantified according to the automatic algorithm recently developed by our 
group7. P-wave morphological analysis was based on a Gaussian fit, i.e. P-wave is modeled by the sum of up to 
8 Gaussian functions. The number of Gaussian functions needed to model the P-wave (model order, N), the 
number of zero crossings (polarity changes, PC) and the sum of relative maxima and minima (Fragmented 
Conduction Index, FCI) of the model have been defined as morphological parameters of the P-wave. Each mor-
phological parameter has been estimated for each lead. For each patient, the model order averaged over the leads 
(Navg) and the sum of the polarity changes (PC) and of the Fragmented Conduction Index (FCI) obtained for each 
lead has been considered (PCsum, FCIsum).
Patients Controls
73 20
Gender (male) 43 (59%) 11 (55%)
Age (years) 69.5 ± 9.3 66.8 ± 6.7
Cardiomyopathies 6 (8%) 2 (10%)
Hypertension 50 (68%) 14 (70%)
Diabetes 5 (6%) 1 (5%)
NYHA Class
 I 62 (85%) 20 (100%)
 II 8 (11%) –
 III 3 (4%) –
 IV – –
 LVEF (%) 61% 62%
 ACE-inhibitors 22 (30%) 8 (40%)
 Sartans 12 (6%) 1 (5%)
 Betablockers 53 (73%) 6 (30%)
 Diuretics 17 (24%) 4 (20%)
 Spironolactone 2 (3%) v
 Ca-channel blockers 8 (11%) 3 (15%)
 Nitrates 1 (2%) –
 Digitals 1 (2%) –
 Antiplatelets 6 (8%) 7 (35%)
 Anticoagulants 61 (84%) 12 (63%)
 Antiarrhythmics 41 (56%) no
 Statine 14 (19%) 3 (15%)
Table 1.  Clinical characteristics of AF patients and controls.
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P-wave variability based on superimposed plots. The superimposition of the P-waves extracted from 
an ECG recording (butterfly plot) is a good visual indicator of the variation over time of the morphology of the 
P-waves. As shown in Fig. 1 (left panels) a butterfly plot of a healthy subject is far different from that of a patient 
suffering from AF. A quantitative indicator of this difference can be the normalized amplitude difference among 
any of the P-waves. For each sample, the difference between the maximum value among the P-waves and the 
minimum value among the P-waves is estimated, obtaining a vector of the amplitude dispersion over time (AD), 
showed in Fig. 1, right panels. Let P(i, j) be the matrix of the P-waves extracted from an ECG recording of one 
patient, with i indicating the sample (i = 1,… , 410) and j indicating the j-th P-wave (j = 1,… , number of P-waves 
in the recording).
Thus the vector AD is obtained as:
µ = −AD i V P i j P i j( )[ ] max{ ( , )} min{ ( , )}
(1)j j
The extracted index of P-wave variability (Amplitude Dispersion Index) is the maximum value of AD divided 
by the maximum value all over the P-waves (in absolute value):
µ =ADI i V
AD i
P i j
( )[ ]
max{ ( )}
max{ ( , )}
(2)
i
i j,
This normalization has been chosen because the maximum value of AD(i) cannot be higher than the maxi-
mum value of all P-waves. Thus, for each patient we have 12 values of ADI; as an index of P-wave variability we 
extracted the mean value of ADI over the 12 leads (ADIavg), expressed in arbitrary units (a.u.).
P-wave variability based on cross-correlation. P-wave variability can be estimated computing the 
cross-correlation coefficients between the P-wave template extracted from a given ECG recording and each 
P-wave of the recording that contributed to the P-wave template calculation. An index of P-wave variability can 
be obtained by averaging the cross-correlation coefficients obtained from the recording (Cross-Correlation Index, 
Figure 1. Butterfly plot of P-waves extracted from an healthy subject (a) and from a patient with a history of 
atrial fibrillation (c).The time course of the amplitude dispersion are showed in (b,d), together with the value of 
amplitude dispersion index (ADI).
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CCI). The higher the index, the lower the P-wave variability. As for ADI, from the 12 values of CCI of each patient 
we extracted the mean value of CCI over the 12 leads (CCIavg), expressed in percentage (%).
P-wave variability based on dynamic time warping. According to the dynamic time warping algo-
rithm the best alignment of waveforms that are similar in shape though out of phase in time can be performed by 
compressing or extending the time axis of the two signals under comparison. The first step of the algorithm is the 
computation of the Warping Function (WF) representing the best alignment between the signals.
In this work, a WF has been computed for each pair of P-waves extracted from a recording. Given two 
P-waves, X and Y:
= …. ….X x , x , x x (3)1 2 i I
= ….. …Y y , y , y y (4)1 2 j J
a matrix G (I × J) is built, whose elements g(i, j) represent the relative distance d(xi, yj) between the two points xi 
and yj in the corresponding sequences. The WF defines a path in G, through a succession of elements g(i, j), rep-
resenting the best alignment between X and Y. The path W can thus be expressed as a sequence W of K elements, 
namely wk = (i, j):
= …. … ≤ ≤ + −W w , w , w , w max(I, J) K I J 1 (5)1 2 k K
The WF describes the minimum cost path. The WF is made of (I + J)/2 elements and can be obtained by searching 
in matrix G the minimum cost path leading from g(I, J) to g(1, 1).
In order to quantify the P-wave variability we extracted the warping index (WI), which is the path length, 
expressed in number of samples. For two identical P-waves, the path length corresponds to the P-wave sample 
length (that is 410 samples hereby). As for ADI and CCI, from the 12 values of WI we had for each patient we 
considered the mean value of WI over the 12 leads (WIavg).
Statistical analysis. Comparison between the two classes of patients (persistent AF and control subjects) 
has been made on the 9 parameters (6 extracted from the template and 3 related to P-wave variability) by non 
parametric Mann-Whitney U-test for unpaired data. Spearman’s correlation coefficients were used to calculate 
correlations among the parameters. A value of p < 0.01 has been considered to be significant. Receiver operat-
ing characteristic curves were used to evaluate the sensitivities and specificities at different cutoff values of each 
parameters.
Results
All AF patients enrolled in this study were successfully cardioverted, and were in sinus rhythm after cardiover-
sion. Wandering pacemaker was diagnosed in no patients. Table 2 shows the results obtained for the AF patients 
and for the control group. All P-wave indices turned out to be significantly different between the two groups, but 
Pdisp. As expected the control group is characterized by shorter P-wave duration and less fragmented P-waves. 
In addition, less P-wave variability over time is associated to control group, as quantified by any of the 3 chosen 
parameters.
Spearman’s correlation coefficients are reported in Table 3. Values reported in bold indicate correlation higher 
than 0.5. Pmin and Pmax are correlated and Pmax correlates even with the P-wave variability parameters: the 
higher the P-wave duration the higher the P-wave variability. The ADI, CCI and WI correlate each other and do 
not correlate with the morphological parameters.
Table 4 shows the values of sensitivity, specificity, area under curve (AUC) and threshold values for each 
parameter studied. The parameters with the best sensitivity and specificity turned out to be Pmax, Pmin, FCI and 
CCI: Pmax > 121 ms and Pmin > 97 ms separated patients from controls, with a sensitivity of 95.9% and a specificity 
of 95%; a FCI > 2.5 separated the two classes with a sensitivity of 89.1% and a specificity of 95%. The P-wave var-
iability parameter CCI showed the highest sensitivity (97.3%) and a good specificity (90%).
If Pmax and CCI are combined, sensitivity and specificity become 98.65 and 100%, respectively. If Navg is also 
used in combination with Pmax and CCI, sensitivity and specificity both reach 100%.
Discussion
This study aimed at analyzing the potential of P-wave variability for indicating atrial modifications caused by 
atrial fibrillation. The link between different P-wave morphologies and different patterns of interatrial conduction 
in patients with AF has been demonstrated8,9. We quantify the P-wave variability over time using three algorithms 
and we extracted three novel indices: one based on the cross-correlation coefficients among the P-waves, one 
associated to variation in amplitude of the P-waves, one sensible to the phase shift among P-waves. In order to 
Pmax (ms) Pmin (ms) Pdisp (ms) Navg (#) FCIsum (#) PCsum (#) CCIavg % ADIavg (a.u.) WIavg (samples)
AF patients 164.8 ± 21.3 146.4 ± 19.8 18.6 ± 8.7 3.02 ± 0.54 37.0 ± 8.1 9.4± 5.9 91.6 ± 4.04 0.98 ± 0.14 636.8 ± 24.6
Controls 87.88 ± 11.6 67.7 ± 11.5 15.9 ± 4.1 2.07± 0.33 24.8 ± 4.2 7.7 ± 2.6 99.3 ± 0.53 0.49 ± 0.20 582.9 ± 24.1
p-value < 0.0001 < 0.0001 0.06 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001
Table 2.  Values of P-wave indices obtained for AF patients and controls.
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investigate the potential of these new indices, we used a population of patients with persistent AF after successful 
cardioversion compared to subjects without history of AF. More standardized time-domain and morphological 
P-wave features have also been estimated.
So far the analysis of the P-wave to stratify AF patients and/or to improve the comprehension of the electro-
physiological mechanisms of the fibrillating atrium has been carried out on P-wave template8,10–14. This analysis 
has been demonstrated to work in extracting indices of AF risk stratification: P-wave duration indices in AF 
patients resulted to be greater than those in the control patients. Indeed, although it is not completely clear if the 
atrial substrate is a cause or a consequence of AF, abnormalities in the P-wave reflect structural changes such as 
increased dispersion of refractoriness, fragmented impulse propagation, atria dilatation and fibrosis which pro-
mote slow and inhomogeneous atrial conduction.
However, the use of signal-averaged P wave is not currently in routine use probably because the methods used 
for P wave analysis vary greatly, and there is an ongoing debate on the appropriate cut-off value for interatrial con-
duction delay. The conflicting results obtained in literature studies are mainly explained by the different designs, 
different methodologies, different patient populations and different endpoints15.
The two most recent and almost simultaneous investigations on the role of P-wave analysis to predict AF 
recurrences after external electrical cardioversion used different acquisition systems and different methodolo-
gies, had similar population (persistent AF) and found different results13,15. Blanche et al. found that none of the 
P-wave parameters was statistically different between patients with and patients without AF recurrences15; Gonna 
et al. reported that parameters associated to P-wave duration were significantly greater in the recurrent AF than 
in the sinus rhythm group13. Both groups concluded that the measurement and use of atrial electrical heteroge-
neity indices need further research to find accurate and reliable risk factors for AF recurrences in patients with 
persistent AF.
Thank to the technological advancements in electronics, ECG recording systems now rely on twice the ampli-
tude resolution respect to 10 years ago, consequently providing a higher signal-to-noise ratio. Thus, it is no more 
mandatory to perform the P-wave analysis on a template, obtained by the averaging technique; it has become 
possible to perform even a beat-to-beat analysis of the P-wave.
Recently Martinez and co-authors investigated the potential of the quantification of the time course variability 
of P-wave features in predicting the onset of AF3,4. According to the atrial electrophysiological changes preceding 
the onset, features like P-wave duration have shown an increasing variability trend, thus suggesting intermittently 
disturbed atrial conduction in patients close to the onset of AF.
In this paper we confirmed these recent findings, demonstrating that, not only the features extracted from the 
P-wave, but also the waveform of the P-waves, changes over time in clinical states of AF. Since no wandering pace-
maker was diagnosed in any patients, these findings suggest that the atrial impulse path varies on a beat-to-beat 
basis.
This approach would allow to exploit unknown aspects of the cardiac impulse atrial path in a heart which has 
already experienced atrial arrhythmias. Atrial conduction disturbance may result in various changes in the atrial 
Pmax (ms) Pmin (ms) Pdisp (ms) Navg (#) FCIsum (#) PCsum (#) CCIavg % ADIavg (a.u.) WIavg (samples)
Pmax (ms) 1 0.945 0.206 0.645 0.624 0.094 −0.655 0.675 0.544
Pmin (ms) 0.945 1 − 0.085 0.645 0.619 0.058 −0.601 0.620 0.471
Pdisp (ms) 0.206 − 0.085 1 0.015 0.055 0.076 − 0.216 0.230 0.282
Navg (#) 0.645 0.645 − 0.015 1 0.826 0.238 − 0.461 0.438 0.487
FCIsum (#) 0.624 0.619 0.055 0.826 1 0.252 − 0.466 0.444 0.464
PCsum (#) 0.094 0.058 0.076 0.238 0.252 1 − 0.126 0.166 0.099
CCIavg % −0.655 −0.601 − 0.216 − 0.461 − 0.466 − 0.126 1 −0.879 −0.902
ADIavg (a.u.) 0.675 0.620 0.230 0.438 0.444 0.166 −0.879 1 0.750
WIavg (samples) 0.544 0.471 0.282 0.487 0.464 0.099 −0.902 0.750 1
Table 3.  Spearman’s correlation coefficients of the p-wave indices.
Sensitivity Specificity Area under curve Threshold value
Pmax (ms) 95.9 95.0 0.94 121.1
Pmin (ms) 95.9 95.0 0.95 97.2
Pdisp (ms) 26.1 80.0 0.44 23.9
Navg (#) 83.6 95.0 0.88 2.5
FCIsum (#) 89.1 95.0 0.84 27
PCsum (#) 23.3 90.0 0.50 12
CCIavg % 98.6 95.0 0.96 0.98
ADIavg (a.u.) 87.7 95.0 0.94 0.85
WIavg (samples) 84.9 95.0 0.88 613.6
Table 4.  Values of sensitivity, specificity, area under curve and threshold values for each parameter studied.
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activation vector and may lead to variations in P wave durations as well as to abnormal and temporary increases 
or decreases in P-wave amplitudes.
The control group was selected among patients without atrial diseases, prior cardiac diseases or history of AF. 
The clinical characteristics of the control group do not differ from those of the persistent AF patients except for 
atrial arrhythmic diseases. Our analysis revealed electrical atrial path of a AF-damaged heart is far different from 
that of a healthy heart: in this latter case, the path is the same, beat after beat, whereas in a heart with a substrate 
damaged by AF, the cardiac impulse passes through different paths, wandering within few beats and even beat 
after beat. Thus our results reveal the presence of impaired interatrial conduction which may also occur tran-
siently on a beat-to-beat basis, similarly to the interatrial blocks2.
The best performing index was the one based on the cross-correlation analysis (CCI), which turned out to 
have good sensitivity and specificity. In control subjects the cross correlation coefficient is always higher than 
0.99, while in AF patients it can reach values as low as 0.8.
The analysis of the P-wave variability should be also considered in the light of the important clinical results 
obtained from the analysis of the T-wave variability (T-wave alternans) in the stratification of patients at risk of 
cardiac arrhythmias. Such an analysis was possible since the first nineties, given the best SNR associated to the 
T-wave, respect to that of the P-wave.
Morphological parameters showed similar sensitivity and specificity obtained in previous papers6,7 and 
resulted useful to investigate the fibrillating atria when used in combination with time-domain or P-wave var-
iability indices. Although Pdisp is considered a marker of anisotropic or inhomogeneous atrial conduction, in 
our population it resulted not to be useful to distinguish patients with persistent AF from controls. As stated 
before, there are conflicting results in literature concerning the analysis of the P-wave in the study of different 
forms of AF. Our population of persistent AF patients consists of both patients who experienced AF recurrences 
after cardioversion and patients who did not. This could explain the higher standard deviation and the poor sta-
tistical significance associated to Pdisp parameter.
It is worth noting that, the ECG resolution needed to detect the morphological P-wave variability is currently 
available in the most modern electrocardiographs present in the market since about 2 years. Older technologies 
are not suitable for such analysis, and its diffusion in worldwide healthcare systems is an obstacle for a wide 
clinical application of the method. Another limitation of the study lies on the small sample size and in the retro-
spective nature of our study. The potential clinical value of the proposed methods could be further investigated in 
larger cohort of patients, and in different experimental models which includes paroxysmal or post-operative AF 
or in screening programs involving subjects aged over 65 years.
Finally, the analysis of the performance of the proposed indices in the prediction of AF recurrences after cardi-
oversion goes beyond the aim of this study, whose objective is to test the reliability of estimating P-wave variability 
and to investigate its potential clinical application.
In conclusion the quantification of the P-wave variability over time can add information in the understanding 
of the association between the anatomical atrial substrate and atrial arrhythmias.
References
1. Baranchuk, A., Conde, D., Enriquez, A. & Bayés de Luna, A. B. P-wave duration or P-wave morphology? Interatrial block: seeking 
for the holy grail to predict AF recurrence. Ann Noninvasive Electrocardiol. 19, 406–408 (2014).
2. Bayés de Luna, A. et al. Interatrial blocks. A separate entity from left atrial enlargement: a consensus report. J Electrocardiol. 45, 
445–451 (2012).
3. Martínez, A., Alcaraz, R. & Rieta, J. J. Study on the P-wave feature time course as early predictors of paroxysmal atrial fibrillation. 
Physiol Meas. 33, 1959–1974 (2012).
4. Martínez, A., Alcaraz, R. & Rieta, J. J. Morphological variability of the P-wave for premature envision of paroxysmal atrial fibrillation 
events. Physiol Meas. 35, 1–14 (2014).
5. Censi, F. et al. Time-domain and morphological analysis of the P-wave. Part I: Technical aspects for automatic quantification of 
P-wave features. Pacing Clin Electrophysiol. 31, 874–883 (2008).
6. Censi, F. et al. Time-domain and morphological analysis of the P wave. Part II: effects of atrial pacing on P-wave features. Pacing Clin 
Electrophysiol. 31, 935–942 (2008).
7. Censi, F. et al. P-wave morphology assessment by a gaussian functions-based model in atrial fibrillation patients. IEEE Trans Biomed 
Eng. 54, 663–672 (2007).
8. Holmqvist, F. et al. Interatrial conduction can be accurately determined using standard 12-lead electrocardiography: validation of 
P-wave morphology using electroanatomic mapping in man. Heart Rhythm 5, 413–8 (2008)
9. Lo, H. M., Lin, J. L., Lin, F. Y. & Tseng, Y. Z. Characteristic P-wave morphology in patients undergoing the atrial compartment 
operation for chronic atrial fibrillation with mitral valve disease. Pacing Clin Electrophysiol. 26, 1864–1872 (2003).
10. Boriani, G. et al. P-wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. Int J Cardiol. 101, 
355–361 (2005).
11. Yoshizawa, T. et al. Prediction of new onset atrial fibrillation through P-wave analysis in 12 lead ECG. Int Heart J. 55, 422–427 
(2014).
12. Kamel, H. et al. P-wave morphology and the risk of incident ischemic stroke in the multi-ethnic study of atherosclerosis, Stroke 45, 
2786–2788 (2014).
13. Gonna, H. et al. P-wave abnormality predicts recurrence of atrial fibrillation after electrical cardioversion: a prospective study. Ann 
Noninvasive Electrocardiol. 19, 57–62 (2014).
14. Guo, X. H., Gallagher, M. M., Poloniecki, J., Yi, G. & Camm, A. J. Prognostic significance of serial P wave signal-averaged 
electrocardiograms following external electrical cardioversion for persistent atrial fibrillation: a prospective study. Pacing Clin 
Electrophysiol. 26, 299–304 (2003).
15. Blanche, C. et al. Usefulness of P-wave signal averaging to predict atrial fibrillation recurrences after electrical cardioversion. Ann 
Noninvasive Electrocardiol. 19, 266–272 (2014).
Acknowledgements
This research is partially funded by the grant GR-2011-02348622 of the Italian Minister of Health.
www.nature.com/scientificreports/
7Scientific RepoRts | 6:26799 | DOI: 10.1038/srep26799
Author Contributions
F.C. developed the software, performed the statistical analysis and wrote the main manuscript text. I.C. and E.R. 
performed all the ECG recordings and contributed to the editing of the main manuscript text. G.C. provided 
intellectual input, contributed to and edited the main manuscript. E.M. and M.T. performed the data analysis for 
features extraction. G.B. supervised the project, provided intellectual input, contributed to and edited the main 
manuscript. All authors analysed the results and reviewed the manuscript.
Additional Information
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Censi, F. et al. P-wave Variability and Atrial Fibrillation. Sci. Rep. 6, 26799; doi: 10.1038/
srep26799 (2016).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
